CBL Control Bionics Ltd
- 0.062
- +0.019+44.19%
Control Bionics Ltd News
Drove Autonomous Wheelchair Gets TGA Approval
Control Bionics (ASX: CBL) has announced that its autonomous wheelchair module, DROVE, has been officially included as a Class 1 Medical Device in the Australian Register of Therapeutic Goods.
Control Bionics Raises AU$130,000 via Additional Commitments for Placement
Medical device company Control Bionics (ASX:CBL) received additional commitments of AU$130,000 for a placement. An additional 3,023,258 ordinary shares will be issued at AU$0.043 apiece, according to
Control Bionics to Raise AU$1 Million via Share Placement
Control Bionics (ASX:CBL) secured firm commitments from professional and sophisticated investors to raise AU$1.04 million, before costs, the medical device company said in a Wednesday filing with the
Control Bionics Appoints Corporate Advisor
Medical device company Control Bionics (ASX:CBL) appointed Lynx Advisors as its corporate advisor, according to a Monday filing with the Australian Securities Exchange. Lynx Advisors is a boutique inv
Control Bionics Appoints CFO
Medical device company Control Bionics (ASX:CBL) named Shannon Boothroyd as chief financial officer, effective May 13, according to a Thursday filing with the Australian Securities Exchange. Boothroyd
Control Bionics Signs Multiple Award Schedule Contract With US Government
Control Bionics (ASX:CBL) obtained a multiple award schedule contract from the US General Services Administration, unlocking direct access to various government buyers to sell its Trilogy solution, ac
Australian Shares Jump to More Than Three-Week High as Central Bank Holds Rates
Australian shares rose to a more than three-week high on Tuesday after the country's central bank kept rates steady as inflation eases at a slower-than-expected rate. The S&P/ASX 200 Index surged 110.
Control Bionics Signs MoU for Japan Launch of NeuroStrip; Shares Up 13%
Control Bionics (ASX:CBL) signed a memorandum of understanding with Japan-based Toho Lamac (TYO:7422) for the commercialization of the company's wearable electromyography device NeuroStrip. The two pa
Control Bionics Ltd. Sees Strong Quarter Amid Challenges
Control Bionics Registers Wearable Device With UK Medical Regulator
Control Bionics (ASX:CBL) registered its wearable electromyography NeuroNode device with the UK Medicines and Healthcare Products Regulatory Agency, according to a filing with the Australian Securitie
Control Bionics Raises AU$1 Million Via Shortfall Placement
Medical device company Control Bionics (ASX:CBL) raised AU$1.0 million via the shortfall placement of 25,809,896 shares at AU$0.04 apiece of a recent nonrenounceable rights issue. This brought total f
Control Bionics Receives AU$480,500 R&D Tax Rebate
Medical device company Control Bionics (ASX:CBL) on Tuesday received a research and development tax rebate of AU$480,501 for fiscal year ended June 30, according to a Wednesday news release. Price (AU
Control Bionics Launches NeuroStrip Wearable Device
Control Bionics (ASX:CBL) launched a new wearable device called NeuroStrip, according to a Thursday news release. NeuroStrip is a portable medical device with sensors to monitor the physical movement
Control Bionics Price Target Cut 84% to A$0.09/Share by Morgans
Control Bionics Price Target Cut 84% to A$0.09/Share by Morgans
Express News | Control Bionics Downgraded to Hold From Speculative Buy by Morgans
Analysis
Price Target
No Data
